Cardiovascular

/Cardiovascular

Novel gene-editing therapy shows promise for patients with transthyretin amyloid cardiomyopathy

Research Highlights:

  • In a clinical trial, a single intravenous infusion of NTLA-2001, a novel gene-editing therapy based on CRISPR/Cas9, significantly reduced abnormal levels of the protein transthyretin in patients with ATTR amyloid cardiomyopathy, a progressive and fatal cause of heart failure.
  • Circulating TTR protein, […]
2022-11-11T00:05:11+08:00 November 11th, 2022|Categories: Cardiovascular|0 Comments

Steroids during surgery may not be helpful for infants having heart bypass

Research Highlights:

  • A multi-center, randomized, placebo-controlled clinical trial with 1,200 infants (younger than age 1) found that administering steroids during heart surgery did not improve post-operative outcomes compared to placebo, and increased the need for low blood glucose requiring insulin treatment.  
  • Investigators found […]
2022-11-10T12:00:12+08:00 November 10th, 2022|Categories: Cardiovascular|0 Comments

Mindfulness shows promise as an effective intervention to lower blood pressure

Research Highlights:

  • Adults with elevated blood pressure who participated in a mindfulness behavior program for eight weeks had significantly lower blood pressure levels and greatly reduced sedentary time, when evaluated at six months follow up.
  • The mindfulness program was focused on attention control, meditation, […]
2022-11-09T23:55:11+08:00 November 9th, 2022|Categories: Cardiovascular|0 Comments

Personalized evaluation for chest pain effective, may eliminate unnecessary testing

Research Highlights:

  • For people with stable chest pain, a personalized “precision” testing approach led to more efficient evaluations for heart disease risk and improved diagnosis and treatment of coronary artery disease when compared to usual care.
  • In a study of more than 2,000 adults […]
2022-11-09T11:50:11+08:00 November 9th, 2022|Categories: Cardiovascular|0 Comments

Diabetes medicine decreased cardiovascular risk in adults with chronic kidney disease

Research Highlights:

  • A new analysis found SGLT-2 inhibitors, a diabetes medication, decreased the risk of cardiovascular death and hospitalization for heart failure, in high-risk patients regardless of whether they have Type 2 diabetes.
  • Pooled results from 13 major trials of empagliflozin and similar medicines […]
2022-11-08T23:45:10+08:00 November 8th, 2022|Categories: Cardiovascular|0 Comments

Restored blood flow meant less pain, better quality of life for those with leg artery disease

Research Highlights:

  • A study of more than 1,800 people with severe peripheral artery disease, or PAD, who were at risk for amputation compared the clinical, safety, quality of life and cost outcomes between those who had bypass surgery and those who had angioplasty […]
2022-11-08T11:40:13+08:00 November 8th, 2022|Categories: Cardiovascular|0 Comments

Maximizing heart failure meds within 2 weeks reduced risk of hospital readmission, death

Research Highlights:

  • A multinational, randomized trial evaluated outcomes for people hospitalized with acute heart failure who received a high-intensity treatment strategy that maximized the doses of heart failure medications within two weeks of hospital discharge in comparison to those who received the standard […]
2022-11-07T23:35:11+08:00 November 7th, 2022|Categories: Cardiovascular|0 Comments

6 common “heart-health” supplements ineffective at lowering cholesterol compared to statins

Research Highlights:

  • Six widely used dietary supplements promoted for improving heart health – including brands of fish oil, cinnamon, garlic and turmeric – were not effective at lowering “bad” cholesterol more than placebo after 28 days of use.
  • However, a common, low-dose cholesterol-lowering medication […]
2022-11-07T11:30:15+08:00 November 7th, 2022|Categories: Cardiovascular|0 Comments

Early use of ECMO devices did not improve outcomes in people with cardiogenic shock

Research Highlights:

  • A randomized trial using extracorporeal membrane oxygenation (ECMO) devices to treat people with cardiogenic shock found that those who received immediate ECMO had comparable outcomes to those who initially received conservative therapy to stabilize blood flow throughout the body (hemodynamic stabilization).
  • 64% […]
2022-11-06T23:25:16+08:00 November 6th, 2022|Categories: Cardiovascular|0 Comments

Intravenous iron improved long-term outcomes for people with heart failure and iron deficiency

Research Highlights:

  • Repeated intravenous (IV) administration of iron reduced the risk of hospitalization for heart failure and cardiovascular death in people with heart failure and iron deficiency, according to a clinical trial in the United Kingdom.
  • Treatment with IV iron was safe and well-tolerated, […]
2022-11-06T11:20:10+08:00 November 6th, 2022|Categories: Cardiovascular|0 Comments